Skip to main content
Clinical Trials/NCT04464655
NCT04464655
Recruiting
Not Applicable

A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease

McGill University Health Centre/Research Institute of the McGill University Health Centre1 site in 1 country2,130 target enrollmentDecember 12, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment
2130
Locations
1
Primary Endpoint
Main finding comparison between SMART CMR and standard CMR in patients with suspected coronary artery disease
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to identify and assess new CMR techniques that can improve current CMR protocols.

Detailed Description

The aim of this study is to develop a comprehensive 10-minute protocol based on function and myocardial tissue characterization without the need for contrast injection, which can be standardized for 70% of cardiac patients. To test this 10-minute CMR protocol for its ability to significantly improve diagnostic decision-making and to reduce cost. To test its clinical feasibility, performance and cost-effectiveness in different populations including: Non-ischemic cardiomyopathies (-)OS-CMR and Ischemic Heart Disease and CAD (+)OS-CMR

Registry
clinicaltrials.gov
Start Date
December 12, 2019
End Date
January 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Responsible Party
Principal Investigator
Principal Investigator

Matthias Friedrich

Principal Investigator

McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • Age: \> 18y, Informed consent No known current or pre-existing significant medical conditions that would affect the cardiovascular or respiratory system

Exclusion Criteria

  • General MRI contraindications: MR- incompatible devices such as pacemakers, defibrillators, or implanted material or foreign bodies. Consumption of caffeinated drinks or foods (including cocoa and chocolate) during the 12 hours prior to the exam.Regular nicotine consumption during the last 6 months
  • Inclusion Criteria:
  • Age: \>18 y, Informed consent, Clinically indicated CMR exam
  • Exclusion Criteria:
  • General MRI contraindications: MR- incompatible devices such as pacemakers, defibrillators, or implanted material or foreign bodies Vasoactive medication (e.g. nitro) during the 12 hours prior to the exam. Consumption of caffeinated drinks or foods (including cocoa and chocolate) during the 12 hours prior to the exam.
  • Regular nicotine consumption during the last 6 months

Outcomes

Primary Outcomes

Main finding comparison between SMART CMR and standard CMR in patients with suspected coronary artery disease

Time Frame: 2019-2025

(Patients with suspected coronary artery disease:) Agreement of the main finding regarding the presence of a coronary territory at risk for inducible myocardial ischemia myocardial derived from OS-CMR, compared with standard first-pass perfusion CMR, using the coronary angiography report as a standard of truth. If the latter is not available, the conclusions based on the results of the standard CMR first pass perfusion scan will be used as the standard of truth.

Primary diagnosis comparison between SMART CMR and standard CMR

Time Frame: 2019-2025

(All patients) Agreement of the suggested primary diagnosis derived from SMART CMR, compared with the diagnosis established from standard CMR protocols, using the final clinical diagnosis as established by the treating physician, as a standard of truth. If the latter is not available, the conclusions based on the results of the standard CMR protocol will be used as the standard of truth.

Secondary Outcomes

  • SMART CMR scan completion percentage(2019-2025)
  • Adverse event monitoring during SMART CMR sequences(2019-2025)
  • Adverse event monitoring during OS-CMR sequence(2019-2025)
  • OS-CMR scan completion percentage(2019-2025)
  • SMART CMR sequence times vs standard protocol sequence times(2019-2025)
  • Septal myocardial T2 vs standard myocardial T2(2019-2025)
  • OS-CMR sequence times vs standard protocol sequence times(2019-2025)
  • Cost comparison of OS-CMR vs standard CMR protocol(2019-2025)
  • Septal myocardial T1 vs standard myocardial T1(2019-2025)
  • SMART-CMR post-stenotic peak flow vs standard CMR flow images(2019-2025)
  • Inter- and intra-scanner variability(2019-2025)
  • Cost comparison of SMART CMR vs standard CMR protocol(2019-2025)
  • Intra- and inter-reader reproducibility(2019-2025)
  • Quantitative parameter comparison between SMART CMR and CINE images(2019-2025)
  • Strain measurements vs standard cine image measurements(2019-2025)

Study Sites (1)

Loading locations...

Similar Trials